Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 650x65px
All >

News > Germany

Total search results: 5820 | Ordered by Date (descending)
1 2 3 ... 57 58 59  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
BioNTech SE. (1/16/20). "Press Release: BioNTech to Acquire Neon to Strengthen Global Leadership Position in T Cell Therapies". Mainz & Cambridge, MA. 2020-01-16
Vivoryon Therapeutics AG. (1/14/20). "Press Release: Vivoryon Therapeutics and Nordic Bioscience Enter Research and Development Collaboration". Halle (Saale) & Herlev. 2020-01-14
MorphoSys AG. (1/13/20). "Press Release: MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab". Planegg & Wilmington, DE. 2020-01-13
NBE Therapeutics AG. (1/10/20). "Press Release: NBE-Therapeutics Closes a USD 22M Series C Financing Round". Basel. 2020-01-10
Boehringer Ingelheim. (1/9/20). "Press Release: Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class Anti-IL-11 Therapies for a Range of Fibrotic Diseases". Ingelheim & Singapore. 2020-01-09
Bayer AG. (1/9/20). "Press Release: Bayer and Exscientia Collaborate to Leverage the Potential of Artificial Intelligence in Cardiovascular and Oncology Drug Discovery". Berlin. 2020-01-09
Evotec SE. (1/9/20). "Press Release: Bayer and Evotec Form New Strategic Alliance Focusing on Polycystic Ovary Syndrome". Hamburg & Berlin. 2020-01-09
Esteve Pharmaceuticals, S.A.. (1/8/20). "Press Release: Esteve Acquires German Proprietary, Specialty, Hospital-focused Company Riemser and Expands Its Presence in Europe". 2020-01-08
Wellington Partners. (1/8/20). "Press Release: Karl Naegler Joins Wellington Partners as Managing Partner". Munich. 2020-01-08
ProBioGen AG. (1/8/20). "Press Release: ProBioGen Inks Next Commercial GlymaxX License with Roche. ADCC-enhancement for Innovative Cancer Therapy". Berlin. 2020-01-08
Eyevensys S.A.S.. (1/8/20). "Press Release: Eyevensys Closes $30M Series B Financing". Paris & Fort Worth, TX. 2020-01-08
PhoreMost Ltd.. (1/7/20). "Press Release: PhoreMost and Boehringer Ingelheim Enter Multi-project Drug Discovery Collaboration". Cambridge. 2020-01-07
Bayer AG. (1/7/20). "Press Release: Bayer Exercises Right to Enter into Follow-on Research and Collaboration Option Agreement with Atomwise. Companies to Continue Crop Protection Development Programs". Monheim & San Francisco, CA. 2020-01-07
Velabs Therapeutics GmbH. (1/7/20). "Press Release: Velabs Therapeutics Receives Exclusive Licence from Alytas Therapeutics for the Development of Therapeutic Antibodies as Senolytics". Heidelberg & Jena. 2020-01-07
genOway S.A.. (1/7/20). "Press Release: genOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnership to All Animal Cell Models". Lyon. 2020-01-07
CureVac AG. (1/7/20). "Press Release: CureVac Announces Positive Results in Low Dose – 1 µg – Rabies Vaccine Clinical Phase 1 Study". Tübingen & Boston, MA. 2020-01-07
Evotec SE. (1/7/20). "Press Release: Evotec and Bristol-Myers Squibb Expand iPSC Collaboration". Hamburg. 2020-01-07
MorphoSys AG. (12/30/19). "Press Release: MorphoSys Announces Submission of Biologics License Application for Tafasitamab in r/r DLBCL to the FDA". Planegg. 2019-12-30
Genmab A/S. (12/19/19). "Press Release: Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics". Copenhagen & Tübingen. 2019-12-19
Merck KGaA. (12/19/19). "Press Release: Merck Licenses Foundational CRISPR Integration Technology to Promega". Darmstadt. 2019-12-19
Boehringer Ingelheim. (12/18/19). "Press Release: Boehringer Ingelheim Discontinues Development of BI 1467335 for NASH". Ingelheim & Sydney. 2019-12-18
Sidekick Health. (12/16/19). "Press Release: Sidekick Partners with Bayer to Provide Digital Therapy Expansion for PAD Patients". 2019-12-16
Sphingotec GmbH. (12/16/19). "Press Release: Sphingotec’s Proprietary Biomarker bio-ADM Detects Residual Congestion in Patients with Heart Failure". Hennigsdorf. 2019-12-16
Boehringer Ingelheim. (12/13/19). "Press Release: Boehringer Ingelheim and Lilly Provide Update on Empagliflozin Phase III Exercise Ability Studies in Chronic Heart Failure". Ingelheim & Indianapolis, IN. 2019-12-13
TU Braunschweig. (12/10/19). "Pressemitteilung: Start-up zu nachhaltiger Antikörper-Produktion Ausgründung der TU Braunschweig arbeitet an breiter Anwendung". 2019-12-10
Algiax Pharmaceuticals. (12/9/19). "Press Release: Algiax Is Ready to Go Into Proof-of-Concept for AP-325 and Welcomes New Investors". Düsseldorf. 2019-12-09
Bruker Corporation. (12/9/19). "Press Release: Bruker Introduces Dedicated Light-Sheet Microscope for Highly Multiplexed 3D Cell Culture Live Imaging". Washington, DC. 2019-12-09
BC Platforms. (12/6/19). "Press Release: BC Platforms Partners with Leading European Genomics Service Provider Center Life & Brain to Expand Genotyping Services Across Europe". Zürich & Boston, MA. 2019-12-06
Eppendorf AG. (12/6/19). "Press Release: Eppendorf with New CEO Dual Leadership. Eva van Pelt and Dr. Peter Fruhstorfer Appointed Co-CEOs – Former CEO, Thomas Bachmann, Left the Company". Hamburg. 2019-12-06
Sartorius AG. (12/5/19). "Press Release: Sartorius Acquires a Majority Stake in Cell Culture Media Specialist Biological Industries". Göttingen. 2019-12-05
Sartorius AG. (12/5/19). "Press Release: Sartorius Supervisory Board Extends Appointment of Group CEO Joachim Kreuzburg". Göttingen. 2019-12-05
4Teen4 Pharmaceuticals GmbH. (12/5/19). "Press Release: Biotech Startup 4Teen4 Pharmaceuticals Closes EUR 7 Million Series A Financing". Hennigsdorf. 2019-12-05
Mologen AG. (12/3/19). "Press Release: Insolvency Filing [Not for publication or distribution in or into US, AU, CA or JP or any jurisdiction in which unlawful]". Berlin. 2019-12-03
Max-Delbrück-Centrum für Molekulare Medizin (MDC). (12/2/19). "Press Release: Deep Learning Identifies Molecular Patterns of Cancer". Berlin. 2019-12-02
Indivumed GmbH. (12/2/19). "Press Release: Indivumed Announces Strategic Partnership with Biognosys". Hamburg & Schlieren. 2019-12-02
CureVac AG. (12/2/19). "Press Release: CureVac Granted Manufacturing Authorization for Its Third GMP Production Suite". Tübingen & Boston, MA. 2019-12-02
BRAIN AG. (12/2/19). "Press Release: New Chairman of the Management Board – Adriaan Moelker Takes Over from Dr Jürgen Eck". Zwingenberg. 2019-12-02
ViGeneron GmbH. (11/28/19). "Press Release: ViGeneron Announces Closing of Series A Financing to Drive Development of Next Generation Gene Therapy Pipeline". Munich. 2019-11-28
Helmholtz-Zentrum für Infektionsforschung (HZI. (11/27/19). "Press Release: Helmholtz Gets Three more Start-ups Off the Ground. HZI Spin-off Myxobiotics Researches Active Substance against Urinary Tract Infections". 2019-11-27
Merck KGaA. (11/26/19). "Press Release: Japan and Singapore Grant CRISPR Patents to Merck". Darmstadt. 2019-11-26
SHS Gesellschaft für Beteiligungsmanagement mbH. (11/26/19). "Press Release: Establishing a New Standard for the Life Science Industry. SHS Supports Internationalization and Further Growth of Single Use Support". Tübingen & Kufstein. 2019-11-26
BCNP Consultants GmbH. (11/25/19). "Press Release: World Café »Digitization of the Coating Industry« at the 4th European Chemistry Partnering on February 27, 2020". Frankfurt a. M.. 2019-11-25
MorphoSys AG. (11/20/19). "Press Release: Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure". Planegg. 2019-11-20
Coulter Partners. (11/20/19). "Press Release: Coulter Partners Opens Brussels Office and Makes Six Strategic Appointments". 2019-11-20
Merck KGaA. (11/20/19). "Press Release: Merck Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations 8Not intended for UK-based media]". Darmstadt. 2019-11-20
Merck KGaA. (11/12/19). "Press Release: Merck Licenses CRISPR Gene-Editing Technology to Evotec". Darmstadt. 2019-11-12
ProBioGen AG. (11/12/19). "Press Release: DirectedLuck, a Transposase for Efficient Gene Delivery and High-Titer Cell Line Development". Berlin. 2019-11-12
4SC AG. (11/12/19). "Press Release: 4SC AG Secures circa EUR 22.4 Million from a Capital Increase [Not for release in US, Australia, Canada, et al.]". Planegg-Martinsried. 2019-11-12
Genedata AG. (11/12/19). "Press Release: Immatics Implements Genedata Biologics into Proprietary T-Cell Receptor Discovery and Engineering XCEPTOR Platform". Basel. 2019-11-12
[iito] Business Intelligence. (11/11/19). "Press Release: [iito] Launches Transatlantic Life Sciences Business Portal at BIO-Europe". Bremen & Hamburg. 2019-11-11
Expedeon AG. (11/11/19). "Press Release: Expedeon AG Signs EUR 120 Million Deal with Abcam for the Sale of Its immunology and Proteomics Business". Heidelberg & Cambridge. 2019-11-11
Numares AG. (11/8/19). "Press Release: University Hospital Regensburg and Numares Present Results for Detection of Acute Kidney Transplant Rejection Based on a Simple Urine Test". Regensburg. 2019-11-08
eGenesis Inc.. (11/7/19). "Press Release: eGenesis Announces $100 Million Series B Financing". Cambridge, MA. 2019-11-07
Owlstone Medical Ltd.. (11/7/19). "Press Release: Owlstone Medical Enters Partnership with Thermo Fisher Scientific to Advance Early Disease Detection Using Non-invasive Breath Biopsy". Cambridge. 2019-11-07
Evotec SE. (11/6/19). "Press Release: Evotec and Vifor Pharma Form Joint Venture for Early Development in Nephrology". Hamburg & St. Gallen. 2019-11-06
SciRhom GmbH. (11/5/19). "Press Release: SciRhom Initiates First-In-Class Antibody Development Program to Treat Major Autoimmune Diseases". Munich. 2019-11-05
Boehringer Ingelheim. (11/4/19). "Press Release: Boehringer Ingelheim and Lilly Modernise Alliance to Focus Full Expertise on Jardiance". Ingelheim & Indianapolis, IN. 2019-11-04
Xlife Sciences AG. (11/4/19). "Press Release: Xlife Siences AG. New Project in the Portfolio". Zurich. 2019-11-04
CEM Corporation. (10/29/19). "Press Release: CEM Corporation Acquires Key Assets of Intavis Bioanalytical Instruments". Matthews, NC. 2019-10-29
Boehringer Ingelheim. (10/29/19). "Press Release: Boehringer Ingelheim Advances First Pan-KRAS Inhibitor BI 1701963 into Clinical Testing". Ingelheim. 2019-10-29
MorphoSys AG. (10/28/19). "Press Release: MOR106 Clinical Development in Atopic Dermatitis Stopped for Futility". Planegg & Mechelen. 2019-10-28
OpGen, Inc.. (10/28/19). "Press Release: OpGen Announces Closing of $9.4 Million Underwritten Public Offering". Gaithersburg, MD. 2019-10-28
Curetis N.V.. (10/28/19). "Press Release: Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test". Vienna & Holzgerlingen. 2019-10-28
OpGen, Inc.. (10/23/19). "Press Release: OpGen Announces Pricing of $9.4 Million Underwritten Offering". Gaithersburg, MD. 2019-10-23
Evotec SE. (10/23/19). "Press Release: Evotec, Integra Holdings and Yissum Establish LAB555 to Fast Track Early-stage Drug Development". Hamburg. 2019-10-23
MCG Motion Capture GmbH. (10/22/19). "Press Release: Motion Capture Group Retains Biotech Alliances International to Raise Series A $15 Million Financing Round". Heidelberg & San Francisco, CA. 2019-10-22
Bluebird Bio, Inc.. (10/22/19). "Press Release: European Medicines Agency Approves Refined Commercial Manufacturing Specifications for Zynteglo". Cambridge, MA. 2019-10-22
Biocat. (10/21/19). "Press Release: Boehringer Ingelheim Joins the d·HEALTH Barcelona Program to Foster Innovation in Health". Barcelona. 2019-10-21
Sartorius AG. (10/21/19). "Press Release: Sartorius Signs Agreement to Acquire Select Danaher Life Science Platform Businesses". Göttingen. 2019-10-21
Danaher Corporation. (10/21/19). "Press Release: Danaher Reaches Agreement to Sell Certain Businesses to Sartorius AG as Part of the GE Biopharma Acquisition Regulatory Process". Washington, DC. 2019-10-21
Abalos Therapeutics GmbH. (10/15/19). "Press Release: Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer". Essen. 2019-10-15
MorphoSys AG. (10/14/19). "Press Release: MorphoSys and I-Mab Biopharma Announce IND Clearance to Initiate Clinical Trials of MOR202/TJ202 for the Treatment of Multiple Myeloma in Mainland China". Planegg & Shanghai. 2019-10-14
Stilla Technologies S.A.S.. (10/10/19). "Press Release: Stilla Technologies Opens U.S. Subsidiary for Direct Commercial Operations Under the Leadership of Life Science Veteran". Beverly, MA. 2019-10-10
Merck KGaA. (10/10/19). "Press Release: Merck Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing". Darmstadt. 2019-10-10
BioNTech SE. (10/10/19). "Press Release: BioNTech Announces Pricing of Initial Public Offering". Mainz. 2019-10-10
iOmx Therapeutics AG. (10/9/19). "Press Release: iOmx Therapeutics Strengthens Executive Management Team and Supervisory Board". Martinsried. 2019-10-09
Evotec SE. (10/9/19). "Press Release: Evotec and Celmatix Enter into Strategic Collaboration". Hamburg & New York, NY. 2019-10-09
Vivoryon Therapeutics AG. (10/8/19). "Press Release: Vivoryon Therapeutics AG Launches Rights Offering to Fund its Phase 2b Clinical Development Program in Alzheimer’s Disease with Strong Commitments [Not for US, et al.]". Halle (Saale). 2019-10-08
Dalhousie University. (10/7/19). "Press Release: Molly Appeal to Help Fund Orbitrap Fusion, Boosting Cancer, Brain, Immunity Research". 2019-10-07
Rentschler Biopharma SE. (10/4/19). "Press Release: Rentschler Biopharma Announces Enhanced Collaboration with Summit Pharmaceuticals International Corporation to Expand Japanese Operation-Base". Laupheim & Milford, MA. 2019-10-04
Bruker Corporation. (10/2/19). "Press Release: Bruker Announces Acquisition of Magnettech’s EPR Business". Freiberg. 2019-10-02
ProBioGen AG. (10/1/19). "Press Release: ProBioGen and Ceva Santé Animale Sign an Exclusive License Agreement to Produce Vectorised Poultry Vaccines Using AGE1.CR Production Technology". Berlin. 2019-10-01
BCNP Consultants GmbH. (9/27/19). "Press Release: 2nd ECP Summer Summit at Henkel HQ, Düsseldorf". Düsseldorf & Frankfurt a. M.. 2019-09-27
BASF SE. (9/27/19). "Press Release: BASF’s Strategy in Agriculture Aims for Innovation-driven Growth in Specific Markets". 2019-09-27
Eppendorf AG. (9/26/19). "Press Release: Eppendorf Significantly Expands Production Site in Oldenburg". Hamburg & Oldenburg in Holstein. 2019-09-26
T3 Pharmaceuticals AG. (9/26/19). "Press Release: Closing of Financing Round and Strengthening of Development Team Paves the Way for T3 Pharma to Enter the Clinic". 2019-09-26
Tacalyx GmbH. (9/25/19). "Press Release: Tacalyx Raises €7 Million in Seed Funding to Generate First in Class Anti-TACA Antibodies for Cancer Treatment". Berlin. 2019-09-25
BioNTech SE. (9/24/19). "Press Release: BioNTech Announces Commencement of Initial Public Offering". Mainz. 2019-09-24
Evotec SE. (9/24/19). "Press Release: Evotec and Takeda Enter Collaboration Agreement to Discover Clinical Candidates across Multiple Therapeutic Areas". Hamburg. 2019-09-24
Boehringer Ingelheim. (9/20/19). "Press Release: Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases". Ingelheim & Newton, MA. 2019-09-20
Universität zu Lübeck (UzL). (9/19/19). "Pressemitteilung: Künstliche Intelligenz. Bund empfiehlt Förderung über zehn Millionen Euro". Lübeck. 2019-09-19
BIO Deutschland. (9/17/19). "Pressemittelung: Biotechnologie-Branchenverband wählt neuen Vorstand. 16. Mitgliederversammlung der BIO Deutschland". Berlin. 2019-09-17
Bayer AG. (9/17/19). "Press Release: Bayer and Informed Data Systems Inc. to Develop One Drop Digital Therapeutics Platform for Multiple Therapeutic Areas [Not intended for U.S. and UK Media]". Berlin. 2019-09-17
AC Immune S.A.. (9/17/19). "Press Release: AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial of Tau PET Tracer PI-2620". Lausanne. 2019-09-17
MorphoSys AG. (9/16/19). "Press Release: MorphoSys's Licensee Janssen Submits Biologics License Application to U.S. FDA of Tremfya (Guselkumab) for Treatment of Adults with Active Psoriatic Arthritis". Planegg. 2019-09-16
High-Tech Gründerfonds Management GmbH. (9/16/19). "Press Release: Chemistry-for-Healthcare Start-up Secures Seed Investment from Investitionsbank Berlin (IBB) and High-Tech Gründerfonds (HTGF)". 2019-09-16
Bruker Corporation. (9/16/19). "Press Release: Bruker Announces Release of Breakthrough diaPASEF Workflow for CCS-aware 4D Proteomics on timsTOF Pro Platform at HUPO 2019". Adelaide. 2019-09-16
Biocrates Life Sciences AG. (9/12/19). "Press Release: Repositioning of Biocrates – Management Change and New Round of Financing". Innsbruck. 2019-09-12
Max Planck Society. (9/12/19). "Press Release: Launch of Tech Transfer Fund KHAN-I". 2019-09-12
Max Planck Society. (9/11/19). "Press Release: Max Planck Society Grants License for New Drug Candidates". 2019-09-11
1 2 3 ... 57 58 59  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top